Search results
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do...
Simply Wall St. via Yahoo Finance· 13 hours agoProtagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 3 days agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 24 hours agoShares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that ...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 18 hours agoShares of Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a ...
Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% Higher
ETF DAILY NEWS· 23 hours agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s share price traded up 4.1% during trading on Friday . Several analysts recently weighed in ...
Relay Therapeutics executive sells over $540k in company stock By Investing.com
Investing.com· 4 days agoRelay Therapeutics, Inc. (NASDAQ:RLAY) executive Peter Rahmer, the company's Chief Corporate...
It Looks Like Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 4 days ago(NASDAQ:NTLA) recently. Shareholders will be interested in what the board will have to say about...
Halozyme Therapeutics (NASDAQ:HALO) Updates FY24 Earnings Guidance
ETF DAILY NEWS· 19 hours agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance ...
Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 12 hours agoBut while history lauds those rare successes, those that fail are often forgotten; who remembers...
Corcept Therapeutics director Swisher sells $66.5k in stock By Investing.com
Investing.com· 4 days agoCorcept Therapeutics Inc. (NASDAQ:CORT) director Daniel N. Swisher Jr. has recently sold shares of...